第 1 到 36 筆結果,共 36 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma | Pan, Yi-Ru; Wu, Chiao-En; Huang, Wen-Kuan; Chen, Ming-Huang; KENG-HSUEH LAN ; Yeh, Chun-Nan | Frontiers in immunology | 2 | 2 | |
2 | 2022 | Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer | Lu, Yu-Cheng; CHAO-YUAN HUANG ; CHIA-HSIEN CHENG ; KUO-HOW HUANG ; YU-CHUAN LU ; PO-MING CHOW ; YI-KAI CHANG ; YEONG-SHIAU PU ; CHUNG-HSIN CHEN ; SHAO-LUN LU ; KENG-HSUEH LAN ; FU-SHAN JAW ; Chen, Pei-Ling; JIAN-HUA HONG | Scientific reports | 2 | 2 | |
3 | 2022 | Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma | Hsu F.-T.; Tsai C.L.; Chiang I.-T.; KENG-HSUEH LAN ; Yueh P.-F.; Liang W.-Y.; Lin C.-S.; Chao Y.; Lan K.-L. | Journal of Cellular and Molecular Medicine | 3 | 1 | |
4 | 2021 | A multipurpose brachytherapy catheter to enable intratumoral injection | Jagodinsky J.C.; Medeiros G.; Raj H.H.; Razuan A.; Locsin A.; Dempsey T.G.; Tang B.; Chakravarty I.; Clark P.A.; Sriramaneni R.N.; Jin W.J.; KENG-HSUEH LAN ; Das R.K.; Miller J.R.; Suarez-Gonzalez D.; Morris Z.S. | Brachytherapy | 0 | 0 | |
5 | 2021 | Real‐world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer | JENNY LING-YU CHEN ; CHAO YUAN HUANG ; YU-SEN HUANG ; CHE-YU HSU ; KENG-HSUEH LAN ; I-LUN SHIH ; WEN-FANG CHENG ; CHI-AN CHEN ; BOR-CHING SHEU ; SUNG-HSIN KUO | Cancers | 1 | 1 | |
6 | 2021 | Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells | KENG-HSUEH LAN ; Tsai C.-L.; Chen Y.-Y.; Lee T.-L.; Pai C.-W.; Chao Y.; Lan K.-L. | Biochemical and Biophysical Research Communications | 1 | 1 | |
7 | 2020 | Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma | Jin, Won Jong; Erbe, Amy K; Schwarz, Ciara N; Jaquish, Abigail A; Anderson, Bryce R; Sriramaneni, Raghava N; Jagodinsky, Justin C; Bates, Amber M; Clark, Paul A; Le, Trang; KENG-HSUEH LAN ; Chen, Yi; Kim, KyungMann; Morris, Zachary S | Frontiers in immunology | 20 | 21 | |
8 | 2020 | Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: A retrospective study | JENNY LING-YU CHEN ; YU-SEN HUANG ; CHAO YUAN HUANG ; CHE-YU HSU ; KENG-HSUEH LAN ; WEN-FANG CHENG ; SUNG-HSIN KUO | Radiation Oncology | 12 | 10 | |
9 | 2020 | Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy | JENNY LING-YU CHEN ; Wang M.-C.; YU-SEN HUANG ; CHAO YUAN HUANG ; Pan C.-K.; CHE-YU HSU ; KENG-HSUEH LAN ; SUNG-HSIN KUO | Journal of X-Ray Science and Technology | 11 | 6 | |
10 | 2019 | Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer | YU-HSUAN CHEN ; CHUN-WEI WANG ; Wei M.-F.; Tzeng Y.-S.; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO | Cancers | 9 | 9 | |
11 | 2018 | Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer | WAN-YU CHEN ; CHEN-TU WU ; CHUN-WEI WANG ; KENG-HSUEH LAN ; HSIANG-KUANG LIANG ; Huang B.-S.; YIH-LEONG CHANG ; SUNG-HSIN KUO ; ANN-LII CHENG | Radiation Oncology | 25 | 25 | |
12 | 2017 | Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells | KENG-HSUEH LAN ; Lee W.-P.; Wang Y.-S.; Liao S.-X. | Oncotarget | 11 | 9 | |
13 | 2017 | Tumor compactness improves the preoperative volumetrybased prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy | CHE-YU HSU ; CHUN-WEI WANG ; Kuo C.-C.; YU-HSUAN CHEN ; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO | Oncotarget | 12 | 12 | |
14 | 2017 | Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia | CHIEN-CHIN LIN ; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; HSIN-AN HOU ; KENG-HSUEH LAN ; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 30 | 30 | |
15 | 2016 | Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation | Hou W.-H.; CHAO-YUAN HUANG ; CHIA-CHUN WANG ; KENG-HSUEH LAN ; CHUNG-HSIN CHEN ; HONG-JENG YU ; SHIH-PING LIU ; Lai M.-K.; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Asian Journal of Andrology | 3 | 1 | |
16 | 2016 | Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy | Wang Y.-J.; CHAO-YUAN HUANG ; Hou W.-H.; CHIA-CHUN WANG ; KENG-HSUEH LAN ; HONG-JENG YU ; Lai M.-K.; SHIH-PING LIU ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Oncotarget | 2 | 1 | |
17 | 2015 | Good tolerance and long-term complete remission after definitive intensity-modulated radiotherapy for locally advanced head and neck cancer in a patient with human immunodeficiency virus infection: A case report and literature review | WAN-YU CHEN ; SUNG-HSIN KUO ; Shen C.-W.; Huang B.-S.; KENG-HSUEH LAN ; Liang H.-K.; CHUN-WEI WANG | Head and Neck | 3 | 2 | |
18 | 2015 | Prolonged treatment time deteriorates positioning accuracy for stereotactic radiosurgery | CHUN-WEI WANG ; HSIANG-KUANG LIANG et al. ; Tseng H.-M.; FU-REN XIAO ; CHANG-MU CHEN ; Cheng W.-L.; Lu S.-H.; KENG-HSUEH LAN ; WAN-YU CHEN ; Liang H.-K.; SUNG-HSIN KUO | PLoS ONE | 18 | 17 | |
19 | 2015 | The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases | YUN CHIANG ; CHIH-HSIN YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO | PLoS ONE | 9 | 9 | |
20 | 2015 | The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer | Wang Y.-J.; CHAO-YUAN HUANG ; Hou W.-H.; CHIA-CHUN WANG ; KENG-HSUEH LAN ; CHUNG-HSIN CHEN ; HONG-JENG YU ; Lai M.-K.; ANN-LII CHENG ; SHIH-PING LIU ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | World Journal of Surgical Oncology | 4 | 4 | |
21 | 2014 | Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resection | HSIANG-KUANG LIANG ; CHUN-WEI WANG ; Tseng, Han-Min; CHAO YUAN HUANG ; KENG-HSUEH LAN ; YU-HSUAN CHEN ; You, San-Lin; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO | Annals of surgical oncology | 8 | 7 | |
22 | 2013 | Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle | KENG-HSUEH LAN | Clinical Science | 20 | 19 | |
23 | 2013 | Clinicopathologic features and responses to radiotherapy of myeloid sarcoma | WAN-YU CHEN ; CHUN-WEI WANG ; Chang C.-H.; Liu H.-H.; KENG-HSUEH LAN ; JIH-LUH TANG ; HWEI-FANG TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG | Radiation Oncology | 25 | 25 | |
24 | 2013 | A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth | KENG-HSUEH LAN | Biochemical and Biophysical Research Communications | 14 | 14 | |
25 | 2012 | Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors | SHIH-FAN LAI ; CHUN-WEI WANG ; YU-HSUAN CHEN ; KENG-HSUEH LAN ; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO | Strahlentherapie und Onkologie | 12 | 11 | |
26 | 2012 | 5-Fluorocytosine combined with Fcy-hEGF fusion protein targets EGFR-expressing cancer cells | KENG-HSUEH LAN | Biochemical and Biophysical Research Communications | 4 | 4 | |
27 | 2009 | 14-3-3ζ overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival | KENG-HSUEH LAN | Cancer Research | 157 | 156 | |
28 | 2007 | Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency | KENG-HSUEH LAN | Clinical Cancer Research | 184 | 166 | |
29 | 2006 | Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide | KENG-HSUEH LAN | Cancer Research | 114 | 105 | |
30 | 2005 | Mechanisms of trastuzumab resistance and their clinical implications | KENG-HSUEH LAN | Annals of the New York Academy of Sciences | 61 | 58 | |
31 | 2005 | ErbB2 promotes Src synthesis and stability: Novel mechanisms of Src activation that confer breast cancer metastasis | KENG-HSUEH LAN | Cancer Research | 88 | 85 | |
32 | 2004 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients | KENG-HSUEH LAN | Cancer Cell | 1564 | 0 | |
33 | 2004 | Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers | KENG-HSUEH LAN | Clinical Cancer Research | 279 | 257 | |
34 | 2004 | PTEN key to Herceptin response in Her2-positive breast cancer | KENG-HSUEH LAN | Cancer Biology and Therapy | |||
35 | 2002 | Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis | KENG-HSUEH LAN | Molecular Cell | 119 | 108 | |
36 | 2002 | Enhanced sensitization to Taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells | KENG-HSUEH LAN | Cancer Research |